Blue dye tested in septic shock: could it help ICU patients?
NCT ID NCT06900140
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study tested whether adding methylene blue to standard care is feasible for adults with septic shock in the intensive care unit. The main goal was to see if a larger trial could be done, not to prove the treatment works. Fifty patients took part, and the study looked at how many could be enrolled and how well they followed the treatment plan.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEPTIC SHOCK are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Lakeridge Health Ajax-Pickering
Ajax, Ontario, Canada
-
Lakeridge Health Oshawa
Oshawa, Ontario, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a key hormone be missing in septic shock?
- Could a simple mineral cut the need for powerful blood-pressure drugs in septic shock?
- Blood filter could shield vessels in septic shock
- Could a simple protein infusion save more lives from septic shock?
- Can a smart algorithm replace expert judgment for critical heart pressure readings?
- Can a simple ultrasound predict organ failure in septic shock?